Benzinga | Feb 25, 2021 04:25PM EST

Acceleron Pharma Q4 EPS $(0.95) Misses $(0.59) Estimate, Sales $25.87M Miss $32.31M Estimate

Acceleron Pharma (NASDAQ:XLRN) reported quarterly losses of $(0.95) per share which missed the analyst consensus estimate of $(0.59) by 61.02 percent. This is a 115.91 percent decrease over losses of $(0.44) per share from the same period last year. The company reported quarterly sales of $25.87 million which missed the analyst consensus estimate of $32.31 million by 19.94 percent. This is a 34.25 percent decrease over sales of $39.34 million the same period last year.